The Pharmacopoeia is a book containing directions for the identification of compound medicines. The role of the European pharmacopoeia consists in helping to protect the public health throughout Europe by focusing on the quality of the medicine and its compounds.
One of the steps in the protection of the public health is pesticide residue analysis on the raw materials of the compounds of these medicines. Primoris is able to analyze these raw materials.
Unless otherwise indicated in the monograph, the herbal drug to be examined at least complies with the limits indicated in table 2.8.13.-1 of the European Pharmacopoeia.
Analyzing pesticide residues on commodities of vegetal origin which are used in the composition of medication, is part of the protection of public health.
As a specialized laboratory, Primoris works together with producers and international organizations to provide reliable analysis methods which aresupporting the needs of the medicinal market.
Are you active in the medical sector and interested in our services, don’t hesitate to contact us.
Primoris is part of relana, the quality circle of a dozen European labs concerning analysis of pesticides and contaminants. Earlier this year Primoris saw a relana audit and received excellent feedback. In the first place the lab shows a high and stable level of quality and furthermore, the auditors were impressed with the competence of our staff.
Due to the efforts of our in-house R&D team, we can now offer a drastically lower reporting time for the analysis of acrylamide, as well as a lowered reporting limit.
On 06/03/2023 the European Commission published regulation 2023/0465 regarding the maximum levels of inorganic arsenic in certain foods.
As of now we will analyse maleic hydrazide (MH) using LC-MS/MS instead of UV, resulting in faster and more precise results.